The extracellular signal-regulated kinase (ERK) pathway: a potential therapeutic target in hypertension

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Pharmacology

Background:

• Hypertension is a major risk factor for severe cardiovascular events like heart attack and stroke.
• Key features of hypertension include heightened vascular smooth muscle cell (VSMC) responsiveness to constrictors and increased VSMC proliferation, leading to vessel wall thickening and reduced lumen diameter.
• Current hypertension treatments often focus on inhibiting vasoconstriction.

Purpose of the Study:

• To review the role of extracellular signal-regulated kinase (ERK) in hypertension.
• To explore the potential of targeting ERK as a therapeutic strategy for hypertension, addressing both contractile hyperresponsiveness and VSMC growth.

Main Methods:

• Review of existing literature on ERK signaling in hypertension.
• Analysis of studies investigating the effects of ERK inhibition on vasoconstriction and VSMC growth in hypertensive models.

Main Results:

• ERK activity is elevated in VSMCs from animal models of hypertension.
• Inhibition of ERK activation has been shown to reduce both VSMC growth and vasoconstriction in these models.
• ERK's involvement in both vasoconstriction and VSMC proliferation makes it a promising therapeutic target.

Conclusions:

• Targeting ERK signaling presents a potential dual therapeutic approach for hypertension, addressing both enhanced contractility and cellular growth.
• Further research into ERK inhibitors could lead to novel pharmacological treatments for hypertension.
• Understanding ERK's role is crucial for developing effective hypertension management strategies.